Boxer Capital Management, LLC Top Holdings and 13F Report (2025) About Boxer Capital Management, LLCInvestment ActivityBoxer Capital Management, LLC has $332.47 million in total holdings as of March 31, 2025.Boxer Capital Management, LLC owns shares of 28 different stocks, but just 13 companies or ETFs make up 80% of its holdings.Approximately 2.53% of the portfolio was purchased this quarter.About 224.76% of the portfolio was sold this quarter.This quarter, Boxer Capital Management, LLC has purchased 60 new stocks and bought additional shares in 2 stocks.Boxer Capital Management, LLC sold shares of 10 stocks and completely divested from 34 stocks this quarter.Largest Holdings Revolution Medicines $46,603,667Nuvalent $31,914,000Merus $29,463,000Avidity Biosciences $25,534,800AnaptysBio $24,167,000 Largest New Holdings this Quarter 83422E204 - Solid Biosciences $4,590,590 Holding24823R105 - Denali Therapeutics $3,400,000 Holding Largest Purchases this Quarter Solid Biosciences 1,240,700 shares (about $4.59M)Denali Therapeutics 250,000 shares (about $3.40M)Prelude Therapeutics 399,827 shares (about $307.87K)Kodiak Sciences 35,000 shares (about $98.35K) Largest Sales this Quarter Revolution Medicines 2,961,487 shares (about $104.72M)Merus 1,200,000 shares (about $50.51M)Nuvalent 670,192 shares (about $47.53M)Avidity Biosciences 862,388 shares (about $25.46M)Legend Biotech 500,000 shares (about $16.97M) Sector Allocation Over TimeMap of 500 Largest Holdings ofBoxer Capital Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorRVMDRevolution Medicines$46,603,667$104,718,181 ▼-69.2%1,317,97714.0%MedicalNUVLNuvalent$31,914,000$47,530,017 ▼-59.8%450,0009.6%MedicalMRUSMerus$29,463,000$50,508,000 ▼-63.2%700,0008.9%MedicalRNAAvidity Biosciences$25,534,800$25,457,694 ▼-49.9%865,0007.7%MedicalANABAnaptysBio$24,167,0000.0%1,300,0007.3%MedicalXENEXenon Pharmaceuticals$20,130,0000.0%600,0006.1%MedicalREPLReplimune Group$17,514,3250.0%1,796,3415.3%MedicalAPLSApellis Pharmaceuticals$15,593,310$15,593,310 ▼-50.0%713,0004.7%MedicalCMRXChimerix$15,403,100$2,127,500 ▼-12.1%1,810,0004.6%MedicalTNGXTango Therapeutics$14,221,9690.0%10,380,9994.3%MedicalELVNEnliven Therapeutics$13,212,3250.0%671,3584.0%MedicalORICORIC Pharmaceuticals$9,667,7460.0%1,732,5712.9%MedicalDAWNDay One Biopharmaceuticals$9,436,2480.0%1,189,9432.8%MedicalKYMRKymera Therapeutics$8,895,250$2,737,000 ▼-23.5%325,0002.7%MedicalPRTAProthena$8,538,7500.0%690,0002.6%MedicalQUREuniQure$7,950,0000.0%750,0002.4%MedicalLEGNLegend Biotech$6,786,000$16,965,000 ▼-71.4%200,0002.0%MedicalNRIXNurix Therapeutics$6,689,2360.0%563,0672.0%MedicalAMLXAmylyx Pharmaceuticals$6,195,0000.0%1,750,0001.9%MedicalSLDBSolid Biosciences$4,590,590$4,590,590 ▲New Holding1,240,7001.4%MedicalDNLIDenali Therapeutics$3,400,000$3,400,000 ▲New Holding250,0001.0%MedicalKODKodiak Sciences$2,908,350$98,350 ▲3.5%1,035,0000.9%MedicalPRLDPrelude Therapeutics$1,623,171$307,867 ▲23.4%2,108,0140.5%MedicalINSTIL BIO INC$1,390,970$4,780,510 ▼-77.5%80,1250.4%COM NEWBOUNDLESS BIO INC$377,5000.0%250,0000.1%COMELYMEliem Therapeutics$176,900$2,998,992 ▼-94.4%145,0000.1%MedicalNUVATION BIO INC$85,3330.0%266,6660.0%*W EXP 02/10/202SRZNWSurrozen$2,0000.0%66,6660.0%MedicalSWTXSpringWorks Therapeutics$0$123,620,276 ▼-100.0%00.0%MedicalAXSMAxsome Therapeutics$0$39,766,700 ▼-100.0%00.0%MedicalSRRKScholar Rock$0$32,415,000 ▼-100.0%00.0%MedicalTYRATyra Biosciences$0$28,184,724 ▼-100.0%00.0%MedicalRCUSArcus Biosciences$0$23,856,758 ▼-100.0%00.0%MedicalGERNGeron$0$21,240,000 ▼-100.0%00.0%MedicalTHRDTF Financial$0$20,580,000 ▼-100.0%00.0%MedicalIMVTImmunovant$0$20,435,250 ▼-100.0%00.0%MedicalARVNArvinas$0$20,293,630 ▼-100.0%00.0%MedicalPSTXPoseida Therapeutics$0$19,200,000 ▼-100.0%00.0%MedicalRCKTRocket Pharmaceuticals$0$18,428,261 ▼-100.0%00.0%MedicalGPCRStructure Therapeutics$0$13,560,000 ▼-100.0%00.0%MedicalKALVKalVista Pharmaceuticals$0$13,467,300 ▼-100.0%00.0%MedicalCGEMCullinan Therapeutics$0$11,058,161 ▼-100.0%00.0%MedicalSpyre Therapeutics Inc$0$10,864,310 ▼-100.0%00.0%COM NEWJasper Therapeutics Inc$0$7,483,000 ▼-100.0%00.0%COM NEWITOSiTeos Therapeutics$0$7,272,307 ▼-100.0%00.0%MedicalIOVAIovance Biotherapeutics$0$5,550,000 ▼-100.0%00.0%MedicalSMMTSummit Therapeutics$0$4,461,250 ▼-100.0%00.0%MedicalTERNTerns Pharmaceuticals$0$4,166,080 ▼-100.0%00.0%MedicalKROSKeros Therapeutics$0$3,957,500 ▼-100.0%00.0%MedicalApogee Therapeutics Inc$0$3,895,800 ▼-100.0%00.0%COMOLMAOlema Pharmaceuticals$0$3,789,500 ▼-100.0%00.0%MedicalMRSNMersana Therapeutics$0$3,768,050 ▼-100.0%00.0%MedicalSANASana Biotechnology$0$2,518,350 ▼-100.0%00.0%MedicalBicara Therapeutics Inc$0$2,351,700 ▼-100.0%00.0%COMRLAYRelay Therapeutics$0$2,208,864 ▼-100.0%00.0%MedicalZNTLZentalis Pharmaceuticals$0$1,363,500 ▼-100.0%00.0%MedicalBDTXBlack Diamond Therapeutics$0$1,082,840 ▼-100.0%00.0%MedicalOBIOOrchestra BioMed$0$952,772 ▼-100.0%00.0%MedicalZURAZura Bio$0$750,000 ▼-100.0%00.0%MedicalMISTMilestone Pharmaceuticals$0$729,257 ▼-100.0%00.0%MedicalBCABBioAtla$0$405,768 ▼-100.0%00.0%MedicalDBV Technologies S A$0$154,500 ▼-100.0%00.0%SPONSORED ADSShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
